A new prognostic model could potentially predict and stratify the risk for hepatocellular carcinoma (HCC) among patients with chronic hepatitis B (CHB) who are noncirrhotic and not indicated for ...

WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma (HCC), according ...

On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has ...

Hepatitis, particularly types B and C, has a profound impact on liver health, often leading to serious conditions like cirrhosis and liver cancer. These viral infections initiate an inflammatory ...

The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.

Patients diagnosed with chronic hepatitis B or C virus infections or cirrhosis should be screened regularly with blood tests and ultrasound to detect hepatocellular cancer at any stage. Baylor ...

Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC ... positive epatitis-B-surface-antigen (HBV), alpha-fetoprotein increase, and echo features including septa, calcification ...

A multicenter, prospective observational study of chemotherapy in elderly patients with biliary tract cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium.

who contract hepatitis B may develop chronic hepatitis B infection. If left untreated this can lead to fibrosis, cirrhosis, hepatocellular carcinoma (HCC) or end-stage liver disease. Hepatitis B is an ...

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCCAmezalpat builds momentum with both ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.